KIKenichi Iwasa

Kenichi Iwasa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kenichi Iwasa has a total of 43 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Reproducible Clinical Response and Serial Electrophysiological Improvement With Efgartigimod in Chronic Inflammatory Demyelinating Polyneuropathy

    by Naoki Omori, Kenichi Iwasa, Shun Aritake, Tomotaka Tanaka, Atsushi Nagai

    Background: Efgartigimod has emerged as a treatment option for chronic inflammatory demyelinating polyneuropathy (CIDP); however, longitudinal electrophysiological changes during treatment and the clinical course after treatment withdrawal remain incompletely characterized. Case Presentation: A woman in her 40s with CIDP showed a favorable but transient response to intravenous immunoglobulin and subsequently received subcutaneous efgartigimod as maintenance therapy. Clinical improvement was accompanied by marked electrophysiological recovery, including restoration of median sensory nerve action potentials and improvement in motor conduction parameters. After approximately 1 year of clinical stability, treatment was temporarily withdrawn, followed by clinical relapse approximately 3 weeks later. After efgartigimod reintroduction, improvement again became apparent after approximately the third administration, closely reproducing the initial treatment course. Conclusions: The relapse after efgartigimod withdrawal and reproducible improvement after reintroduction support the potential role of efgartigimod as maintenance therapy in this patient. Serial nerve conduction studies may provide an objective adjunct for assessing electrophysiological response during treatment.

  • Open Access

    Digital completion time relates more strongly to Alzheimer's disease‐type atrophy than to vascular burden in a community cohort

    by Kenichi Iwasa, Naoki Omori, Manabu Ishida, Tomotaka Tanaka, Atsushi Nagai

    INTRODUCTION: Slowing on digital cognitive testing may reflect Alzheimer's disease (AD)‐type atrophy, small‐vessel disease, or both. Single‐outcome studies cannot determine whether slowing preferentially reflects one type of brain change or general brain health. We tested whether response‐time features from the tablet‐based Cognitive Assessment for Dementia, iPad version 2 (CADi2) were more strongly associated with AD‐type atrophy than with vascular burden. METHODS: In 1163 community‐dwelling adults undergoing brain‐health screening (Izumo cohort, 2019–2025), CADi2 response‐time features predicted two primary MRI markers from one framework under repeated nested cross‐validation: Alzheimer's disease likelihood score (ADLS; similarity to an AD‐type atrophy pattern) and normalized white matter lesion (WML) volume. The primary metric was the incremental observed–predicted correlation (Δ R ) over age and sex. Silent brain infarcts, microbleeds, and a composite small vessel disease score were additional vascular outcomes. RESULTS: CADi2 features improved prediction of ADLS (Δ R = +0.054, 95% confidence interval [CI] +0.010 to +0.095) but not WML (Δ R = −0.006). The improvement reflected completion time, not accuracy. Because predictive headroom differed, we repeated the comparison in residual space. There, the increment correlated about twice as strongly with ADLS as with WML ( r = 0.160 vs. 0.080; p = 0.044), although both remained significant. A parallel contrast against the composite vascular score gave Δ r = 0.100 ( p = 0.008). DISCUSSION: Digital completion time was preferentially, but not exclusively, associated with AD‐type atrophy (neurodegeneration axis) relative to vascular burden. Because ADLS indexes an atrophy pattern rather than amyloid or tau pathology, these cross‐sectional findings characterize a structural phenotype.

  • Open Access

    Systolic blood pressure and future stroke risk by asymptomatic brain lesions in a community MRI cohort: a retrospective study

    by Kenichi Iwasa, Naoki Omori, Shun Aritake, Yoshihito Aoki, Yukie Kanai, Atsushi Nagai

    Asymptomatic brain lesions (ABLs), including white matter hyperintensities (WMHs), silent brain infarcts (SBIs), and cerebral microbleeds (CMBs), are common MRI markers of cerebral small-vessel disease and predictors of future stroke. However, the optimal blood pressure (BP) target for primary prevention in individuals with ABLs remains unclear. We analyzed 2363 neurologically healthy adults (mean age 61.9 ± 10.9 years; 54% men) who underwent brain MRI screening (“Brain Dock”) and were followed for incident stroke over a mean of 8.9 years. ABLs were defined as the presence of SBI, WMH (Fazekas grade ≥ 2), or CMBs. The association between systolic BP (SBP) and stroke risk was evaluated using Cox proportional hazards models with restricted cubic splines, stratified by ABL status, and adjusted for age, sex, HbA1c, LDL-C, and antihypertensive use. The interaction between SBP and the ABL status was not significant. Stroke risk increased progressively with increasing SBP in both groups. In the ABL-positive group, the risk appeared to increase at comparatively lower SBP levels; however, this observation was descriptive and should not be interpreted as indicating a specific threshold. Due to limited stroke events and wide confidence intervals, particularly at higher SBP levels, these spline-based patterns should be considered exploratory rather than definitive. However, confirmation in larger prospective cohorts and interventional studies is needed before MRI-defined cerebrovascular markers can inform clinical blood pressure strategies.


  • Open Access

    Cross-cultural adaptation, reliability, and preliminary construct validity of the Japanese version of the Parkinson’s disease pain classification system

    by Shuhei Ishida, Tomohiko Nishigami, Akira Mibu, Masahiro Manfuku, Hirofumi Yamashita, Yuta Tomooka, Norimasa Egusa, Shigeto Moriwaki, Kenichi Iwasa, Keiko Yamada, et al.

  • Cognitive test completion time as an indicator of early brain atrophy: Findings from the Cognitive Assessment for Dementia, iPad version 2 (CADi2) in healthy adults

    by Kenichi Iwasa, Masahiro Takamura, Manabu Ishida, Yoko Kuroda, Satoshi Abe, Atsushi Nagai

    Background: Although several cognitive screening tools are available, early-stage detection remains challenging because individuals in prodromal or mild cognitive impairment stages often score within normal ranges. Assessment of response time, rather than test score alone, may offer greater sensitivity to subtle decline. Objective: To examine whether completion time on the Cognitive Assessment for Dementia, iPad version 2 (CADi2), is associated with early brain changes suggestive of preclinical dementia. Methods: In this cross-sectional study of 511 cognitively unimpaired adults (290 men, 221 women; mean age, 61 years) at the Health Science Center, Japan, participants completed the 10-item CADi2 and underwent structural magnetic resonance imaging. Based on the ceiling effects in total scores, we analyzed associations between total test duration and regional brain atrophy. Results: CADi2 time was significantly associated with hippocampal atrophy, while total scores were not. We applied a deep survival analysis model using Alzheimer's Disease Neuroimaging Initiative data to estimate 5-year dementia risk. Using a threshold of ≥0.25, receiver operating characteristic analysis showed that CADi2 time (area under the curve, 0.632) outperformed CADi2 (0.554) and Mini-Mental State Examination (0.582) scores. Only CADi2 time showed a significant odds ratio [OR] for high dementia risk (OR = 1.94; 95% confidence interval: 1.12–3.40; p = 0.018) after adjusting for covariates. Conclusions: These findings indicate that completion time from a cognitive test without ceiling effects is more suitable than score-based measures for evaluating the predementia stage and that combining time and score metrics may further improve stratification in cognitively normal individuals.


  • Open Access

    A Hot-Spring Water Improves Inflammatory Conditions in an Injury-Induced Atopic Dermatitis Mouse Model by Regulating Skin Barrier Function

    by Yoko Naito, Abdullah Md. Sheikh, Jubo Bhuiya, Fatema Binte Abdullah, Jerin Fahmida, Shatera Tabassum, Hiro Tamegai, Kenichi Iwasa, Shozo Yano, Atsushi Nagai

    Background: Atopic dermatitis (AD) is a common inflammatory skin condition in which skin barrier function plays a crucial role. Hot spring water is known for its beneficial effects on skin health. This study investigates the impact of a hot spring water on AD pathology, focusing on skin barrier function. Methods: Using the tape-stripping method, we induced an AD mouse model, treated the mice with either hot-spring water or tap water, and assessed time-dependent changes in skin barrier function, histology, and AD-related proteins. Results: Transepithelial water loss (TEWL) was significantly increased after tape-stripping, which began to decrease from day 2 in both treatment groups. On day 3, water loss was significantly decreased in hot-spring-treated mice than tap water-treated mice. Histological analysis revealed thickening and vacuolization of the stratum spinosum from day 2, becoming more pronounced on day 3 in tap-water-treated mice. However, in hot-spring-treated mice, the stratum spinosum was significantly less thickened, and the stratum granulosum was better formed. Immunostaining showed that transient receptor potential vanilloid 4 (TRPV4) levels decreased at day 2 but returned to baseline by day 3, with no significant differences between groups. Filaggrin, a key skin barrier protein, was markedly low in tape-stripped areas at day 0, but increased progressively, with a higher level in the upper epidermis of hot-spring-treated mice compared to tap-water-treated counterparts. Additionally, hot spring water treatment significantly reduced CD8+ T cell numbers and IL-4 cytokine levels, mitigating inflammation. Conclusions: Threfore, hot spring water enhances skin barrier recovery and reduces inflammation in AD.

  • Open Access

    A Hot-Spring Water Improves Inflammatory Conditions in an Injury-Induced Atopic Dermatitis Mouse Model by Regulating Skin Barrier Function

    by Yoko Naito, Abdullah Md Sheikh, Jubo Bhuiya, Fatema Binte Abdullah, Jerin Fahmida, Shatera Tabassum, Hiro Tamegai, Kenichi Iwasa, Shozo Yano, Atsushi Nagai

    Atopic dermatitis is a common inflammatory skin condition in which skin barrier function plays a crucial role. Hot spring water is known for its beneficial effects on skin health. This study investigates the impact of a hot spring water on atopic dermatitis pathology, with a focus on skin barrier function. Using the tape-stripping method, we induced an atopic dermatitis mouse model, treated the mice with either hot-spring water or tap water, and assessed time-dependent changes in skin barrier function, histology, and atopic dermatitis-related proteins. Transepithelial water loss (TEWL) experiments showed a significant increase in water loss after tape-stripping, which began to decrease from day 2 in both treatment groups. By day 3, water loss had significantly decreased in hot spring-treated mice compared to tap water-treated mice. Histological analysis revealed thickening and vacuolization of the stratum spinosum from day 2, becoming more pronounced on day 3 in tap water-treated mice. However, in hot spring-treated mice, the stratum spinosum was significantly less thickened, and the stratum granulosum was better formed. Immunostaining showed that transient receptor potential vanilloid 4 (TRPV4) levels decreased at day 2 but returned to baseline by day 3, with no significant differences between groups. Filaggrin, a key skin barrier protein, was markedly low in tape-stripped areas at day 0 but increased progressively, with a higher level in the upper epidermis of hot spring-treated mice compared to tap water-treated counterparts. Additionally, hot spring water treatment significantly reduced CD8+ T cell numbers and IL-4 cytokine levels, mitigating inflammation. These findings suggest that hot spring water enhances skin barrier recovery and reduces inflammation in atopic dermatitis.

  • Effect of high-fat diet on cerebral pathological changes of cerebral small vessel disease in SHR/SP rats

    by Yuchi Zhang, Abdullah Md. Sheikh, Shatera Tabassum, Kenichi Iwasa, Abu Zaffar Shibly, Xiaojing Zhou, Ruochen Wang, Jubo Bhuiya, Fatema Binte Abdullah, Shozo Yano, et al.

    Cerebral small vessel diseases (CSVD) are neurological disorders associated with microvessels, manifested pathologically as white matter (WM) changes and cortical microbleeds, with hypertension as a risk factor. Additionally, a high-fat diet (HFD) can affect peripheral vessel health. Our study explored how HFD affects cerebral small vessels in normotensive WKY, hypertensive SHR, and SHR/SP rats. The MRI results revealed that HFD specifically increased WM hyperintensity in SHR/SP rats. Pathologically, it increased WM pallor and vacuolation in SHR and SHR/SP rats. Levels of blood–brain barrier (BBB) protein claudin 5 were decreased in SHR and SHR/SP compared to WKY, with HFD having minimal impact on these levels. Conversely, collagen IV levels remained consistent among the rat strains, which were increased by HFD. Consequently, HFD caused vessel leakage in all rat strains, particularly within the corpus callosum of SHR/SP rats. To understand the underlying mechanisms, we assessed the levels of hypoxia-inducible factor-1α (HIF-1α), Gp91-phox, and neuroinflammatory markers astrocytes, and microglia were increased in SHR and SHR/SP compared to WKY and were further elevated by HFD in all rat strains. Gp91-phox was also increased in SHR and SHR/SP compared to WKY, with HFD causing an increase in WKY but little effect in SHR and SHR/SP. In conclusion, our study demonstrates that HFD, in combined with hypertension, intensifies cerebral pathological alterations in CSVD rats. This exacerbation involves increased oxidative stress and HIF-1α in cerebral vessels, triggering neuroinflammation, vascular basement membrane remodeling, IgG leakage, and ultimately WM damage. Graphical Abstract


  • Open Access

    Time required for psychological testing of dementia is useful for predicting asymptomatic brain lesions: validation using CADi2

    by Kenichi Iwasa, Masahiro Takamura, Yoko Kuroda, Kosuke Asayama, Shun Aritake, Satoshi Abe, Atsushi Nagai

    Cognitive test duration is related to brain lesions. However, few studies have addressed automated timing. CADi2 is a cognitive evaluation software. This study aimed to evaluate the use of automatically calculating the time required to answer questions in a 10-item in CADi2, in addition to the questionnaire score, to assess cognitive function and estimate asymptomatic brain lesions. Among 556 patients who underwent a brain scan at the Shimane Institute of Health Science between March 28, 2019 and March 24, 2021 and interacted with CADi2, we enrolled 429 patients aged ≥ 50 years with paraventricular and deep subcortical white matter hyperintensity scores of ≥ 2 as per the Fazekas classification, microbleeds, and asymptomatic brain lesions. CADi2 total time was more accurate at predicting the presence of a silent brain infarction (SBI) than the Mini-Mental State Examination Particularly, the time required to answer questions 2, 7, and 8 was related to the presence of SBI. The odds ratio of having SBI was 3.75 (2.00–7.05) when using the summed time to answer these three questions. The time required for cognitive testing using CADi2 is useful for predicting the presence of asymptomatic lesions and could be used as a non-invasive, prehospital stroke risk screening tool.